Table 2. Characteristics of the ‘pot+’ and ‘pot−’ populations.
‘Pot−’ group
|
‘Pot+’ group
|
||||
---|---|---|---|---|---|
Clinical parameters and outcome variables | Nb | % (95% CI) | Nb | % (95% CI) | P |
Age | |||||
<55 years old | 18 | 30.5% [18.8–43.3] | 14 | 29.2% [16.3–42.0] | 0.894 |
55–65 years old | 22 | 37.3% [24.9–44.6] | 20 | 41.6% [27.7–55.6] | |
>65 years old | 19 | 32.2% [20.3–44.1] | 14 | 29.2% [16.3–42.0] | |
Gender | |||||
Male | 54 | 91.5% [84.4–98.6] | 40 | 83.3% [72.8–93.9] | 0.197 |
Female | 05 | 08.5% [02.8–18.7] | 08 | 16.7% [07.5–30.2] | |
Tumour differentiation | |||||
Well differentiated | 26 | 44.1% [31.4–56.7] | 18 | 37.5% [23.8–51.2] | 0.777 |
Moderately differentiated | 27 | 45.7% [33.1–58.5] | 24 | 50.0% [35.9–64.1] | |
Poorly differentiated | 06 | 10.2% [03.8–20.8] | 06 | 12.5% [04.7–25.3] | |
pT | |||||
pT1 | 22 | 37.3% [24.9–49.6] | 12 | 25.0% [12.8–37.3] | 0.150 |
pT2 | 10 | 17.0% [08.4–29.0] | 05 | 10.4% [03.5–22.7] | |
pT3 | 27 | 45.7% [33.1–58.5] | 31 | 64.6% [51.1–78.1] | |
pN | |||||
N0 | 41 | 69.5% [57.7–81.2] | 25 | 52.1% [38.0–66.2] | 0.065 |
N1 | 18 | 30.5% [18.8–42.3] | 23 | 47.9% [33.8–62.0] | |
Vascular invasion | |||||
No | 45 | 76.3% [65.4–87.1] | 27 | 56.2% [42.2–70.3] | 0.028 |
Yes | 14 | 23.7% [12.9–34.6] | 21 | 43.8% [29.7–57.8] | |
Local recurrence | |||||
No | 45 | 76.3% [65.4–87.1] | 26 | 54.2% [40.1–68.3] | 0.016 |
Yes | 14 | 23.7% [12.9–34.6] | 22 | 45.8% [31.7–59.9] | |
Metastasis | |||||
No | 45 | 76.3% [65.4–87.1] | 11 | 22.9% [11.0–34.8] | <0.001 |
Yes | 14 | 23.7% [12.9–34.6] | 37 | 77.1% [65.2–89.0] | |
Total | 59 | 100% | 48 | 100% |
Nb=number of patients, 95% CI=95% confidence interval, P=significance of the difference between ‘pot−’ and ‘pot+’ groups.